Filtered By:
Condition: Arthritis
Vaccination: Meningitis Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 139 results found since Jan 2013.
Non-protective immunity after standard pneumococcal vaccination series identified as a potential contributing risk factor for refractory otolaryngologic conditions in children
CONCLUSION: In pediatric patients with recurrent infectious otolaryngologic disease refractory to traditional medical and surgical therapy, inadequate responses to pneumococcal vaccination may be revealed. This correlation represents a potential pathway for diagnosis and therapy.PMID:37386844 | DOI:10.1177/00034894231182745
Source: The Annals of Otology, Rhinology, and Laryngology - June 30, 2023 Category: ENT & OMF Authors: Caroline A Bonaventure Adele K Evans Source Type: research
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases
Int Immunopharmacol. 2023 Jun 3;120:110342. doi: 10.1016/j.intimp.2023.110342. Online ahead of print.ABSTRACTWe conducted a single-centre retrospective cohort study in a French University Hospital between 2010 and 2018 to describe the risk of severe infectious event (SIE) within 2 years after the date of first rituximab infusion (T0) prescribed after the evidence of acquired hypogammaglobulinemia (gamma globulins [GG] ≤ 6 g/L) in the setting of autoimmune diseases (AID) other than rheumatoid arthritis. SIE occurred in 26 out of 121 included patients. Two years cumulative incidence rates were 12.7 % (95 % CI 5.1-23.9) in ...
Source: International Immunopharmacology - June 5, 2023 Category: Allergy & Immunology Authors: Xavier Boumaza Margaux Lafaurie Emmanuel Treiner Ondine Walter Gregory Pugnet Guillaume Martin-Blondel Damien Biotti Jonathan Ciron Arnaud Constantin Marie Tauber Florent Puisset Guillaume Moulis Laurent Alric Yves Renaudineau Dominique Chauveau Laurent S Source Type: research
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study
CONCLUSION: The MenACWY conjugate vaccine was immunogenic in the vast majority of JIA and IBD patients at adolescent age, but seroprotection was lower in patients using anti-TNF agents. Therefore, an extra booster MenACWY vaccination should be considered.PMID:37198018 | DOI:10.1016/j.vaccine.2023.04.056
Source: Vaccine - May 17, 2023 Category: Allergy & Immunology Authors: Milou Ohm Joeri W van Straalen Marieke Zijlstra Gerrie de Joode-Smink Anne Jasmijn Sellies Joost F Swart Sebastiaan J Vastert Joris M van Montfrans Marije Bartels Annet van Royen-Kerkhof Joanne G Wildenbeest Caroline A Lindemans Victorien Wolters Roos A W Source Type: research
Engaging Multistakeholder Perspectives to Identify Patient-Centered Research Priorities Regarding Vaccine Uptake Among Adults With Autoimmune Conditions
CONCLUSION: A multistakeholder group identified key topics as critically important priorities for future research to decrease vaccine hesitancy and improve uptake of vaccines for adults with autoimmune conditions.PMID:37127530 | DOI:10.1002/acr2.11546
Source: Herpes - May 1, 2023 Category: Infectious Diseases Authors: Shilpa Venkatachalam Kelly Gavigan Laura Stradford Vandana Dronadula Angela Degrassi W Benjamin Nowell Shubhasree Banerjee Peter A Merkel Michael D George Jennifer Gordon Dianne G Shaw Kalen Larsen Lisa Emrich Robert N McBurney Hope Sullivan Ashira Blazer Source Type: research
Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
ConclusionOur data suggest that many different interventions can increase PCV rates. It appears that barrier-oriented interventions may have the greatest positive effect on increasing PCV uptake. However, clinicians should be encouraged to implement measures best suited to their practice. Future high-quality randomized controlled trials are needed to determine the best approach to optimize vaccination rates.Graphical Abstract
Source: Digestive Diseases and Sciences - April 6, 2023 Category: Gastroenterology Source Type: research
Pediatric case of septic arthritis due to Streptococcus pneumoniae serotype 19A
Braz J Infect Dis. 2023 Jan 31;27(2):102742. doi: 10.1016/j.bjid.2023.102742. Online ahead of print.ABSTRACTIn recent years, the incidence of pediatric septic arthritis caused by Streptococcus pneumoniae has been quite low. The pneumococcal conjugate vaccine PCV10 is the available vaccine included in the Bulgarian national immunization program. PCV10 reduces the incidence of invasive diseases, but non-vaccinal serotypes like 19A, the etiologic agent of the case of septic arthritis reported herein in a 3-year-old boy. The synovial fluid was positive for S. pneumoniae. The patient was treated with vancomycin during hospitali...
Source: Braz J Infect Dis - February 2, 2023 Category: Infectious Diseases Authors: Preslava M Hristova Hristina Y Hitkova Nikolay K Balgaranov Raina Т Gergova Alexandra S Alexandrova Source Type: research
Single-centre, cross-sectional study on the factors and reasons for non-vaccination among patients with rheumatoid arthritis
CONCLUSIONS: We found that the factors associated with non-vaccination varied by vaccine type; therefore, vaccinations should be promoted with individualised strategies.PMID:36702156 | DOI:10.1093/mr/road003
Source: Herpes - January 26, 2023 Category: Infectious Diseases Authors: Hirofumi Miyake Ryuichi Minoda Sada Yukio Tsugihashi Kazuhiro Hatta Source Type: research
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis
Vaccine. 2022 Dec 7:S0264-410X(22)01499-2. doi: 10.1016/j.vaccine.2022.11.075. Online ahead of print.NO ABSTRACTPMID:36496283 | DOI:10.1016/j.vaccine.2022.11.075
Source: Vaccine - December 10, 2022 Category: Allergy & Immunology Authors: J Nagel G J önsson J- Å Nilsson C Manuswin M Englund T Saxne M C Kapetanovic Source Type: research
CME: Neuroborreliosis
Praxis (Bern 1994). 2022;111(14):779-787. doi: 10.1024/1661-8157/a003939.ABSTRACTCME: Neuroborreliosis Abstract. Lyme disease is the most common infectious disease transmitted by ticks throughout Europe. Bacteria of the Borrelia burgdorferi complex are transmitted via tick bites to humans. The typical initial presentation is a localized infection of the skin (Erythema migrans). If the patient is not treated with antibiotics, a disseminated infection might occur, presenting as neurological Lyme disease, Lyme carditis, Lyme arthritis or Acrodermatitis chronica atrophicans. A neuroborreliosis occurs in 3-15% of the cases. It ...
Source: Praxis - October 26, 2022 Category: General Medicine Authors: Laura Iven-Assmann Katarzyna Szajek Rolf Sturzenegger Alexia Cusini Thomas Fehr Source Type: research
